Abstract
Anticancer drug-induced tumor suppression may involve mechanisms of protection against neoplastic transformation that are normally latent in mammalian cells and consist in a genetic program implemented during anti-tumoral defense. This defense program results in the self elimination of cells harboring potentially dangerous mutations by triggering cell death through apoptosis and/or autophagy or in the execution of a program that leads to a permanent growth arrest known as senescence. These responses are considered crucial tumor suppressive mechanisms and their study appears to be essential to develop therapeutical procedures based on the enhancement of the different responses. This review summarizes fundamental knowledge on the underlying mechanisms able to limit excessive or aberrant cellular proliferation and on the prognostic value of both apoptosis and senescence detection. In addition, interesting evidence showing that different drugs induce senescence or cell death depending on the genetic features of the tumor cells as well as on the integrity of the relative pathways is reported.
Keywords: Senescence, apoptosis, autophagy, cancer therapy
Current Medicinal Chemistry
Title: Senescence and Cell Death Pathways and Their Role in Cancer Therapeutic Outcome
Volume: 16 Issue: 3
Author(s): M. V. Chiantore, S. Vannucchi, G. Mangino, Z. A. Percario, E. Affabris, G. Fiorucci and G. Romeo
Affiliation:
Keywords: Senescence, apoptosis, autophagy, cancer therapy
Abstract: Anticancer drug-induced tumor suppression may involve mechanisms of protection against neoplastic transformation that are normally latent in mammalian cells and consist in a genetic program implemented during anti-tumoral defense. This defense program results in the self elimination of cells harboring potentially dangerous mutations by triggering cell death through apoptosis and/or autophagy or in the execution of a program that leads to a permanent growth arrest known as senescence. These responses are considered crucial tumor suppressive mechanisms and their study appears to be essential to develop therapeutical procedures based on the enhancement of the different responses. This review summarizes fundamental knowledge on the underlying mechanisms able to limit excessive or aberrant cellular proliferation and on the prognostic value of both apoptosis and senescence detection. In addition, interesting evidence showing that different drugs induce senescence or cell death depending on the genetic features of the tumor cells as well as on the integrity of the relative pathways is reported.
Export Options
About this article
Cite this article as:
Chiantore V. M., Vannucchi S., Mangino G., Percario A. Z., Affabris E., Fiorucci G. and Romeo G., Senescence and Cell Death Pathways and Their Role in Cancer Therapeutic Outcome, Current Medicinal Chemistry 2009; 16 (3) . https://dx.doi.org/10.2174/092986709787002691
DOI https://dx.doi.org/10.2174/092986709787002691 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multiple Mechanisms of Cytokine Action in Neurodegenerative and Psychiatric States: Neurochemical and Molecular Substrates
Current Pharmaceutical Design Cardio-Vascular Risks Associated with Clozapine Treatment
Current Psychiatry Reviews Chronic Hepatitis C, Insulin Resistance and Vascular Disease
Current Pharmaceutical Design Tachykinins and their Receptors in Human Malignancies
Current Drug Targets Interview: Dr. Muin J. Khoury Discusses the Future of Public Health Genomics and why it Matters for Personalized Medicine and Global Health
Current Pharmacogenomics and Personalized Medicine Pharmacogenomics in Drug Induced Liver Injury
Current Drug Metabolism Primary Antiphospholipid Syndrome and Pulmonary Hypertension
Current Pharmaceutical Design Preface
Letters in Drug Design & Discovery Stroke in Women
Recent Patents on Cardiovascular Drug Discovery Inflammatory Biomarkers in Peripheral Artery Disease: Diagnosis, Prognosis, and Therapeutic Challenges
Current Medicinal Chemistry Primary and Secondary Insomnia: Prevalence, Causes and Current Therapeutics
Current Medicinal Chemistry - Central Nervous System Agents Chemistry and Biology of Indoles and Indazoles: A Mini-Review
Mini-Reviews in Medicinal Chemistry Perioperative Safety of Warfarin Therapy and Reversal
Current Drug Safety Chest Pain in Children
Current Pediatric Reviews Antibody-Mediated Endothelial Cell Damage Via Nitric Oxide
Current Pharmaceutical Design Fibrate-Associated Adverse Effects Beyond Muscle and Liver Toxicity
Current Pharmaceutical Design Effects of CYP2C19 Polymorphism on Endothelial Function, Arterial Stiffness and Inflammation in Coronary Artery Disease Patients Under Clopidogrel Treatment
Current Pharmaceutical Design NAD in Skin: Therapeutic Approaches for Niacin
Current Pharmaceutical Design p66 Shc as the Engine of Vascular Aging
Current Vascular Pharmacology Medical Treatment of Aortic Aneurysms in Marfan Syndrome and other Heritable Conditions
Current Cardiology Reviews